0000899243-17-012696.txt : 20170510
0000899243-17-012696.hdr.sgml : 20170510
20170510214614
ACCESSION NUMBER: 0000899243-17-012696
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170508
FILED AS OF DATE: 20170510
DATE AS OF CHANGE: 20170510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pernosky Lawrence R
CENTRAL INDEX KEY: 0001673555
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 17832359
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-08
0
0000896262
AMEDISYS INC
AMED
0001673555
Pernosky Lawrence R
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
Chief Human Resources Officer
Common Stock
2017-05-08
4
M
0
8876
27.35
A
30093
D
Common Stock
2017-05-08
4
S
0
12281
58.65
D
17812
D
Common Stock
2017-05-09
4
M
0
11500
27.35
A
29312
D
Common Stock
2017-05-09
4
S
0
10900
58.75
D
18412
D
Common Stock
2017-05-09
4
S
0
600
59.25
D
17812
D
Common Stock
2017-05-10
4
M
0
2124
27.35
A
19936
D
Common Stock
2017-05-10
4
M
0
5626
27.35
A
25562
D
Common Stock
2017-05-10
4
M
0
3750
27.35
A
29312
D
Common Stock
2017-05-10
4
S
0
11300
58.99
D
18012
D
Common Stock
2017-05-10
4
S
0
200
57.83
D
17812
D
Common Stock
2017-05-08
4
S
0
214.9897
58.45
D
0
I
Through 401(k) Plan
Stock Option (Right to Buy)
27.35
2017-05-08
4
M
0
8876
0.00
D
2025-05-01
Common Stock
8876
36124
D
Stock Option (Right to Buy)
27.35
2017-05-09
4
M
0
11500
0.00
D
2025-05-01
Common Stock
11500
24624
D
Stock Option (Right to Buy)
27.35
2017-05-10
4
M
0
2124
0.00
D
2025-05-01
Common Stock
2124
22500
D
Stock Option (Right to Buy)
27.35
2017-05-10
4
M
0
5626
0.00
D
2025-05-01
Common Stock
5626
5624
D
Stock Option (Right to Buy)
27.35
2017-05-10
4
M
0
3750
0.00
D
2025-05-01
Common Stock
3750
7500
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.30 to $59.06, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.20 to $59.01, inclusive.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.22 to $59.29, inclusive.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.62 to $59.27, inclusive.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.70 to $57.96, inclusive.
The reporting person was granted 45,000 time-based stock options (the "Time-Based Stock Options") on May 1, 2015. The Time-Based Stock Options are subject to time-based vesting conditions. The Time-Based Stock Options vested in equal, 25% installments on each of May 1, 2016 and May 1, 2017 and will vest in equal, 25% installments on each of May 1, 2018 and May 1, 2019, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Time-Based Stock Options.
On May 1, 2015, the reporting person was granted 11,250 performance-based stock options (the "2015 Tranche Stock Options") that were subject to achievement of identified performance goals for fiscal year 2015, which the Compensation Committee of the Issuer's Board of Directors has certified as achieved. The 2015 Tranche Stock Options are subject to additional time-based vesting conditions (2,813 vested on May 1, 2016, 2,813 vested on May 1, 2017, 2,812 will vest on May 1, 2018 and 2,812 will vest on May 1, 2019), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the 2015 Tranche Stock Options.
On May 1, 2015, the reporting person was granted 11,250 performance-based stock options (the "2016 Tranche Stock Options") that were subject to achievement of identified performance goals for fiscal year 2016, which the Compensation Committee of the Issuer's Board of Directors has certified as achieved. The 2016 Tranche Stock Options are subject to additional time-based vesting conditions (one-third vested on May 1, 2017, and one-third will vest on each of May 1, 2018 and May 1, 2019), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the 2016 Tranche Stock Options.
/s/ David L. Kemmerly, pursuant to a power of attorney
2017-05-10